OTC · Biotechnology

Mosaic ImmunoEngineering Inc. (CPMV) Stock

$0.55 +65.36% OTC: CPMV Healthcare

Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology.

Valuation

MetricValue
Price$0.55
Market Cap$3.98M
P/E Ratio-6.11
P/B Ratio-0.52
P/S Ratio0.00
EPS (TTM)$-0.09
52-Week High$1.05
52-Week Low$0.31
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE9.22%
ROA-692.47%
ROCE9.67%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.19
Current Ratio0.00

Annual Financials (USD)

Metric20202021202220242025
Revenue—$0$0$0$0
Operating Profit—$-4.0M$-3.0M$-1.0M$-1.0M
Net Profit—$-4.0M$-2.0M$-1.0M$-1.0M
EPS—$-0.55$-0.33$-0.13$-0.09
Op Margin—————

Balance Sheet (USD)

Metric20202021202220242025
Total Assets$0$0$0$0$0
Total Liabilities$1.0M$3.0M$5.0M$7.0M$7.0M
Cash$0$0$0$0$0
Borrowings$0$1.0M$1.0M$2.0M$2.0M

Cash Flow (USD)

Metric20202021202220242025
Operating Cash Flow—$-1.0M$-1.0M$0$0
Investing Cash Flow—$0$0$0$0
Financing Cash Flow—$1.0M$0$0$0
Net Cash Flow—$0$0$0$0
Free Cash Flow$0$-1.0M$-1.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.09
EV / EBITDA-8.96
FCF Yield-4.19%
Quick Ratio0.00
Interest Coverage-9.88
Return 1Y-33.93%
Return 3Y-48.77%
Return 5Y—

Ownership

Insiders Held88.68%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
West Oak Capital, LLC12025-09-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BETRFBetterLife Pharma Inc. $0.15 -7.50% -16.80 $23.96M 0.00%
BIXTBioxytran, Inc. $0.02 +1.49% -0.91 $2.37M 0.00%
BZYRBurzynski Research Institute, Inc. $0.00 — -0.41 $525794 0.00%
CUBTCurative Biotechnology, Inc. $1.00 +0.00% -2.81 $6.82M 0.00%
GLWLFGlow Lifetech Corp. $0.03 +0.00% -19.57 $6.16M 0.00%

About Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.

Mosaic ImmunoEngineering Inc. is headquartered in US.

Mosaic ImmunoEngineering Inc. (CPMV) stock trades at $0.55 with a market capitalization of $3.98M. The stock is valued at a price-to-earnings (P/E) ratio of -6.11, price-to-book of -0.52, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.31 and $1.05, and currently trades 47.6% below its 52-week high.

On profitability, Mosaic ImmunoEngineering Inc. generates a return on equity (ROE) of 9.22%, return on capital employed of 9.67%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.mosaicie.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides